Sector
MiscellaneousOpen
₹23Prev. Close
₹23Turnover(Lac.)
₹0Day's High
₹23Day's Low
₹2352 Week's High
₹45.352 Week's Low
₹14.88Book Value
₹63.82Face Value
₹10Mkt Cap (₹ Cr.)
12.56P/E
8.65EPS
2.66Divi. Yield
016 May 2024
12:00 AM
AGM
Announcement Date: 16 May, 2024
16 May 2024
12:00 AM
BookCloser
30 Jan 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.46 | 5.46 | 5.46 | 5.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 28.66 | 27.16 | 30.51 | 38.27 |
Net Worth | 34.12 | 32.62 | 35.97 | 43.73 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1.45 | 1.7 | 1.69 | 2.38 |
yoy growth (%) | -14.82 | 0.76 | -28.89 | 0 |
Raw materials | 0 | 0 | -0.06 | -1.56 |
As % of sales | 0 | 0 | 3.96 | 65.44 |
Employee costs | -0.95 | -1.36 | -3.13 | -1.63 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.13 | 0.04 | -2.13 | -0.68 |
Depreciation | -0.65 | -0.91 | -0.55 | -0.34 |
Tax paid | -0.02 | 0.14 | -0.3 | -0.15 |
Working capital | -1.93 | -0.33 | 0.33 | -2.12 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -14.82 | 0.76 | -28.89 | 0 |
Op profit growth | -123.45 | -93.08 | 2.21 | -20.11 |
EBIT growth | 326 | -119.15 | 175.04 | -80.53 |
Net profit growth | -99.47 | -88.61 | 264.41 | -123.91 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 11.69 | 11.93 | 12.95 | 7.4 | 9.38 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 11.69 | 11.93 | 12.95 | 7.4 | 9.38 |
Other Operating Income | 0.97 | 0.6 | 0.14 | 0 | 0 |
Other Income | 1.78 | 0.66 | 1.64 | 1.93 | 2.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
GMR Airports Ltd GMRAIRPORT | 84.6 | 0 | 89,328.94 | -49.43 | 0 | 270.92 | 45.21 |
International Gemmological Institute (India) Ltd IGIL | 345.85 | 33 | 14,946.24 | 139.14 | 0.71 | 234.2 | 50.61 |
Embassy Developments Ltd EMBDL | 91.46 | 0 | 11,181.33 | -15.26 | 0 | 4.83 | 45.78 |
Rites Ltd RITES | 219.4 | 28.57 | 10,544.45 | 94.99 | 4.1 | 544.53 | 51.59 |
CMS Info Systems Ltd CMSINFO | 434.2 | 19.89 | 7,085.41 | 79.12 | 1.32 | 521.96 | 124.32 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec & Non-Independent Dir
Sanjay N Mehta
Non-Exec & Non-Independent Dir
Pradip K Desai
Managing Director
Viral Pradipkumar Desai
Whole Time Director & CFO
Paras Desa
Non Executive Director
Shefali Desai
Company Sec. & Compli. Officer
Urvi Shinde
Independent Director
Jigneshkumar R Desai
Independent Director
Nirav D Jogani
Chairman & Independent Directo
Rajendra N Chokhawala
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Span Divergent Ltd
Summary
Incorporated on 31st March 1980 as Private Ltd. Co. and converted into a Public Ltd. Co. on 14th August 1993. Promoted by Dr.P.K.Desai. The Company is engaged in manufacturing a wide range of microbiological, immunological and bio-chemical diognostic reagents, plastic accessories and allied products in its plant at Udhna.The Company completed expansion-cum-modernisation and mechanisation of packing activities at Udhna. Acquiring three plots of land at GIDC Sachin admeasuring 33,897 sq. mtrs. which is situated near the State Highway and National Highway No.8.This project was finance by way of internal accruals of Rs.31.62 lakhs and balance from Term Loans of Rs.30 lakhs.The Company entered into the technical arrangement with Bioprobe Netherland, Path U.S.A. Dynajen U.S.A. for manufacturing HIV Dipsticks, Myco-dot, Monoclonal anitbodies.Company launched several new products developed by its R & D Center such as One Step Lateral Chromotography Based Assay for monitoring of pregnancy and Hepatitis to be marketed under the brand name of CRYSTAL as well as HIV Flow Through. The continuation distributorship arrangements with Murex Biotech UK Ltd which is now subsidiary of Abbott Diagnostics USA will also generate substantial business from the nitche market of the Blood Bank Segment.
Read More
What is the Span Divergent Ltd share price today?
The Span Divergent Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹23 today.
What is the Market Cap of Span Divergent Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Span Divergent Ltd is ₹12.56 Cr. as of 05 May ‘25
What is the PE and PB ratio of Span Divergent Ltd?
The PE and PB ratios of Span Divergent Ltd is 8.65 and 0.36 as of 05 May ‘25
What is the 52 Week High and Low of Span Divergent Ltd?
The 52-week high/low is the highest and lowest price at which a Span Divergent Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Span Divergent Ltd is ₹14.88 and ₹45.3 as of 05 May ‘25
What is the CAGR of Span Divergent Ltd?
Span Divergent Ltd's CAGR for 5 Years at 14.01%, 3 Years at 19.41%, 1 Year at 54.57%, 6 Month at -17.65%, 3 Month at -19.66% and 1 Month at -15.69%.
What is the shareholding pattern of Span Divergent Ltd?
The shareholding pattern of Span Divergent Ltd is as follows:
Promoters - 64.00 %
Institutions - 0.00 %
Public - 36.00 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
